GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Short-Term Debt

Yumanity Therapeutics (FRA:8IY) Short-Term Debt : €0.00 Mil (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Short-Term Debt?

Yumanity Therapeutics's Short-Term Debt for the quarter that ended in Sep. 2022 was €0.00 Mil.

Yumanity Therapeutics's quarterly Short-Term Debt declined from Mar. 2022 (€1.05 Mil) to Jun. 2022 (€0.55 Mil) and declined from Jun. 2022 (€0.55 Mil) to Sep. 2022 (€0.00 Mil).

Yumanity Therapeutics's annual Short-Term Debt increased from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€2.38 Mil) and increased from Dec. 2020 (€2.38 Mil) to Dec. 2021 (€5.14 Mil).


Yumanity Therapeutics Short-Term Debt Historical Data

The historical data trend for Yumanity Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Short-Term Debt Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Short-Term Debt
- 2.38 5.14

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.83 5.14 1.05 0.55 -

Yumanity Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Yumanity Therapeutics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines